Transdermal Patch "Transfilm®" – topical & transdermal

Transdermal Patch Transfilm® – topical & transdermal
Product Description

Our Transfilm® is a non-dissolving patch system for dermal or transdermal delivery of your API. The delivery of a drug via a transdermal route of application offers the best of oral and intravenous administration. Avoidance of the first-pass effect leads to better bioavailability and may result in fewer side effects. Consistent and controlled drug delivery can minimize or avoid periods of under- and overdosing. Transdermal patches deliver drugs over a longer period of time, thus allowing for reduced dosing frequency. A transdermal patch is administered by the patients themselves and administration is stopped by removal of the patch. Contrary to intravenous drips or infusion pumps, patient activity is not restricted. These numerous benefits lead to significantly improved patient compliance and as a consequence transdermal patches like our Transfilm® can offer a critical edge to new and established drugs in competitive markets.

Read more Show less

tesa Labtec GmbH

  • DE
  • 2015
    On CPhI since
  • 2
    Certificates
View company profile
Sample request Get a quote
Categories
more categories Show less
Specifications
  • Supplied from
    Germany
More specifications Fewer specifications
Sales Markets
Show more Show less

tesa Labtec GmbH

  • DE
  • 2015
    On CPhI since
  • 2
    Certificates
View company profile

More Products from tesa Labtec GmbH

  • Oral film Mucofilm® - mucoadhesive film

    Product Oral film "Mucofilm®" - mucoadhesive film

    Our Mucofilm® offers intra- or transmucosal delivery. Our mucoadhesive film technology is designed for immediate release, directional or controlled release of your API. A thin film, which harbors your API, is applied to the mucosa of the oral cavity. After application, the film is small, light and cannot be felt by the patient. The Mucofilm® technology can be developed to deliver the API into the mucosa for local treatment, e.g. inflammations. We can also modify the technology to facilitate transmucosal permeation of the API to achieve a systemic delivery treating the whole body. This will prevent the API from the so called first-pass effect which is the mayor reason for a low oral bioavailability. We can design our Mucofilm®  according to clients target profile and controll the disintegration of the film from seconds to hours. 
  • Oral Film Rapidfilm® – our orodispersible film

    Product Oral Film "Rapidfilm®" – our orodispersible film

    Our orodispersible Rapidfilm® works like a conventional or orodispersible tablet. The film is placed on the tongue and dissolves within a few seconds. The active ingredient is swallowed together with the saliva and takes the same route as a tablet via the liver where the drug is metabolized.  Depending on whether the drug shall become effective within seconds or only after hours, we offer a broad variety of formulation alternatives in order to meet our customer’s individual need. So a fast onset as well as a slow release form of our Rapidfilm® can be offered. Since many drugs do not provide a convenient taste, we are also capable in masking the taste of the active ingredient.  Moreover, an oral dissolvable film can also be an attractive dosage form for an already existing product offering the stated advantages and limiting risks and costs for the development of a new Rx or OTC product.
show all products

tesa Labtec GmbH resources

  • Video Oral films

    If you are looking for new innovative drug delivery dosage forms, then have a look at our unique technologies: 

    The Rapidfilm® releases your API immediately and delivery is through the gastro-intestinal route. The uptake is very convenient and easy. The  Rapidfilm® is placed on the tongue and dissolves within a few seconds. The active ingredient is swallowed together with the saliva and takes the same route as a tablet via the liver where the drug is metabolized.

    Our Mucofilm® is a thin film, which harbors your API and is adhered to the oral mucosa. The film is small, cannot be felt and offers a much better convenience to the patient. The technology can be developed to deliver the API into the mucosa for local treatment (e.g. inflammations) or modified to achieve a systemic delivery through the mucosa treating the whole body

  • Brochure tesa Labtec Company Flyer

  • Video Transdermal films

    Our Transfilm® is a non-dissolving patch system for dermal or transdermal delivery of your API.
    The delivery of a drug via a transdermal route of application offers the best of oral and intravenous administration. Avoidance of the first-pass effect leads to better bioavailability and may result in fewer side effects. Consistent and controlled drug delivery can minimize or avoid periods of under- and overdosing. Transdermal patches deliver drugs over a longer period of time, thus allowing for reduced dosing frequency. A transdermal patch is administered by the patients themselves and administration is stopped by removal of the patch. Contrary to intravenous drips or infusion pumps, patient activity is not restricted. 

  • Video The world of tesa Labtec in 2 Minutes

    If you are looking for a strong partner for development and manufacture of innovative oral films and transdermal patches for the pharmaceutical industry worldwide, welcome at tesa Labtec. We are your full service CDMO and always BY YOUR SIDE - FROM IDEA TO MARKET.

Recommended products